"Coastal Cardiology aims to deliver world class care and compassionate service to each patient through dedicated clinical practice, continued quality improvement, and a commitment to patient satisfaction, with the ultimate goal of improving both patient and community health status. Please visit our website for a list of our providers and services. We look forward to caring for you!"

During the past decade, Charleston Cardiology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charleston Cardiology" #1 sponsor was "Forest Laboratories" with 2 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "AtheroGenics" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charleston Cardiology" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Charleston Cardiology" are "Atrial Fibrillation" (2 trials), "Bradycardia" (2 trials), "Hypertension" (2 trials), "Atherosclerosis" (1 trials) and "Atrial Arrhythmia" (1 trials). Many other conditions were trialed in "Charleston Cardiology" in a lesser frequency.

Most popular intervention types in "Charleston Cardiology" are "Drug" (8 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Azimilide Dihydrochloride" (2 trials), "Darusentan" (2 trials), "Guanfacine" (2 trials) and "AGI-1067" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charleston Cardiology" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Charleston Cardiology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Charleston Cardiology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Charleston Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".